Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure
Clinical and Translational Medicine · 2023-09 · 13 (9)
DOI: 10.1002/ctm2.1372 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical and Translational Medicine, online erschienen am 15.09.2023. Verfasst von Jishnu Malgie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Hemodynamic Monitoring, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
ORCID-Profile: Jishnu Malgie
Zitieren
APA
Malgie, J., Brugts, J. J., & de Boer, R. A. (2023). Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure. Clinical and Translational Medicine, 13(9). https://doi.org/10.1002/ctm2.1372
Vancouver
Malgie J, Brugts JJ, de Boer RA. Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure. Clinical and Translational Medicine. 2023;13(9). doi:10.1002/ctm2.1372
BibTeX
@article{Malgie2023,
author = {Malgie, Jishnu and Brugts, Jasper J and de Boer, Rudolf A},
title = {Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure},
journal = {Clinical and Translational Medicine},
year = {2023},
volume = {13},
number = {9},
doi = {10.1002/ctm2.1372}
}
EUVIMED